GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE Supporting healthcare Professionals In the fight against resistance
Surveillance is an essential component in the fight against Antimicrobial Resistance Lord Kevin, 1824-1907
THE FIRST POINT PREVALENCE SURVEY ON ANTIBIOTICS AND RESISTANCE, AT GLOBAL LEVEL Created in 2015
➜ In 2017 2018 and after… Created in 2015 50 400 100,000 THE FIRST POINT PREVALENCE SURVEY ON ANTIBIOTICS AND RESISTANCE, AT GLOBAL LEVEL ➜ In 2017 Created in 2015 50 countries 400 hospitals 100,000 patients 2018 and after…
THE FIRST POINT PREVALENCE SURVEY ON ANTIBIOTICS AND RESISTANCE, AT GLOBAL LEVEL ➜ 2018 and after… ➜ In 2017
POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE A “One day” picture of antimicrobial use and resistant organisms in an hospital Surgery ICU Medicine
POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE Which antibiotics? Doses? Duration? Treatment or prevention? Empiric treatment? Targeted treatment? Diagnosis? Ward? Guidelines compliance? Stop/review date? Reason in note? Diagnostic tests? Bacteria? Resistance mechanisms? POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE A “One day” picture of antimicrobial use and resistant organisms in an hospital Surgery ICU Patients on antibiotics Medicine
ACCESSIBLE TO ALL HOsPITALS IN THE WORLD BUILT ON A VoLONTARY BASIS Support local antimicrobial stewardship activities Assess effectiveness of interventions through repeated PPS Help implement local antibiotic guidelines Benchmark with other hospitals, countries
A UNIQUE DATABASE FOR SCIENTIFIC AND EPIDEMIOLOGY RESEARCH Opportunity for local and international networking Stimulate discussions between hospitals wards Provide data in countries where there is no surveillance data A unique tool for cross sectional and longitudinal surveys
JOIN A UNIQUE NETWORK JOIN GLOBAL PPS www.global-pps.com
bioMérieux is the sole sponsor of the GLOBAL Point Prevalence Survey bioMérieux is the sole sponsor of the GLOBAL Point Prevalence Survey. The funder has no role in study design, data collection, data analysis, data interpretation, or writing the report. Data are strictly confidential and stored anonymous at the coordinating centre of the University of Antwerp.